The EHA-SWG Scientific Meetings have been developed as a joint effort of the EHA Scientific Working Groups (SWGs) and EHA to intensify the beneficial collaboration. The meetings are designed to create a high quality scientific program and to share in-depth scientific knowledge with hematologists around the world. In particular, these meetings provide an innovative format that includes e.g. discussions with patient organizations, regulators and pharmaceutical companies. Besides that voting boxes are used for the self-assessment of participants. The meetings attract 80 to 150 delegates.
The meetings are funded by EHA through sponsorship from corporate partners. In addition, various sponsorship opportunities are created for each meeting specifically. For further information on sponsorship opportunities, please contact EHA at firstname.lastname@example.org.
Here's an overview of the upcoming Scientific Meetings, including details on the program, registration and abstract submission.
EHA-SWG Scientific Meeting
Immunotherapy: The advent of CAR T cell therapy for hematologic malignancies
Dates: February 14-16, 2019
Location: Amsterdam, The Netherlands
EHA-SWG Scientific Meeting: Focus on Granulocytes and Constitutional Marrow Failure Disorders & Leukemia Predisposing Genes
Dates: October 10-12, 2019
EHA-SWG Scientific Meeting on Erythropoiesis Defects
Dates: November 7-9, 2019
EHA-SWG Scientific Meeting on Systemic Risk of Thrombosis or Bleeding
Dates: November 21-23, 2019